PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Translational Clinical Research Program, Institut Hospital del Mar d\'Investigacions Mèdiques (IMIM), Barcelona, Spain.\', \'Epidemiology and Public Health, Institut Hospital del Mar d\'Investigacions Mèdiques, Barcelona, Spain.\', \'CIBER de Epidemiología Y Salud Pública (CIBERESP), Barcelona, Spain.\', \'Center for Research in Occupational Health (CISAL), Institut Hospital del Mar d\'Investigacions Mèdiques (IMIM), Barcelona, Spain.\', \'Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.\', \'Pompeu Fabra University (UPF), Barcelona, Spain.\', \'Department of Medicine, Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.\', \'Catalan Institute for Research and Advanced Studies (ICREA), Barcelona, Spain.\', \'Department of Pathology, Hospital del Mar, Barcelona, Spain.\', \'Department of Cell Biology, Physiology and Immunology, Universitat Autonoma de Barcelona, Barcelona, Spain.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3389/fimmu.2021.737083
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 34539673
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • The mRNA-1273 Vaccine Induces Cross-Variant Antibody Responses to SARS-CoV-2 With Distinct Profiles in Individuals With or Without Pre-Existing Immunity.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all